SG/CALL/CVS HEALTH/100/0.1/17.01.25 Share Price

Warrant

DE000SQ86V93

Market Closed - Deutsche Boerse AG 20:44:38 31/05/2024 BST
0.031 EUR +29.17% Intraday chart for SG/CALL/CVS HEALTH/100/0.1/17.01.25
Current month-16.22%
1 month-16.22%
Date Price Change
31/05/24 0.031 +29.17%
30/05/24 0.024 +50.00%
29/05/24 0.016 +14.29%
28/05/24 0.014 -26.32%
27/05/24 0.019 +11.76%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 08:44 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SQ86V9
ISINDE000SQ86V93
Date issued 16/02/2023
Strike 100 $
Maturity 17/01/2025 (230 Days)
Parity 10 : 1
Emission price 0.84
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.84
Lowest since issue 0.007
Spread 0.01
Spread %23.81%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
59.6 USD
Average target price
70.17 USD
Spread / Average Target
+17.73%
Consensus